Wednesday, August 1, 2012

Are the Concerns of Investor Hushed? Alnylam Achieves RNAi Milestone

Alnylam Pharmaceuticals, a Cambridge-based biotechnology firm, has received a (Dollar) 3.2m milestone payment f ... http://p.ost.im/p/debPCF
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)